Cytk corporate
WebApr 8, 2024 · Ticker: CYTK CIK: 1061983 Form Type: Proxy Statements Form DEF 14A Accession Number: 0000950170-22-005509 Submitted to the SEC: Fri Apr 08 2024 4:05:47 PM EST Accepted by the SEC: Fri Apr 08 2024 Period: Tuesday, May 10, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media SEC.gov WebJul 23, 2024 · SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of its previously announced underwritten public offering of...
Cytk corporate
Did you know?
Web1 day ago · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebApr 10, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 …
WebWe Prevent Cyber Attacks Cybersecurity & Compliance For Small & Medium Businesses Take Your Free Risk Assessment 0 Million Endpoints deployed utilizing our systems 0 + Clients protected with Cytek Services … WebMar 16, 2024 · NASDAQ: CYTK Cytokinetics (CYTK) Insider Trading Activity 619 Followers Portfolio Trend: No Trend Detected CYTK Insider Transactions Transactions Price Apr '22 Jul '22 Oct '22 Jan '23 12 6 1 5 10 $31 $37 $43 $49 $55 The data in the graph is based on publicly available reports of insider transactions, as reported to the SEC.
WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%. WebApr 11, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …
WebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle …
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) ... Senior Vice President, Corporate Communications, Investor Relations high school for performing and visual artsWebFeb 23, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that SEQUOIA-HCM ( S afety, E fficacy, and Q uantitative U nderstanding of O bstruction I mpact of Aficamten in HCM ), a Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic … how many cheetah in indiaWebCytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as … high school for mentally illWebApr 11, 2024 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. how many cheetahs are aliveWebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., Mar. 1, 2024 - Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the fourth quarter and full year 2024. Net loss for the fourth quarter was $137.4 million or $1.45 per share and the net loss for the year 2024 was $389.0 million or $4.33 per share. high school for performing artsWebI’m CYTK. The First Mobile App for Automotive Repair The next leap forward in AI-powered mobile applications, CYTK’s touch and voice search technology provides quick access to … how many cheetah in worldWebApr 9, 2024 · Over the last 90 days, insiders sold 64,738 shares of company stock valued at $2,556,804. 5.00% of the stock is currently owned by corporate insiders. Cytokinetics Stock Up 0.7 % Shares of... how many cheetahs are left in the world